David J. Kellman

David J. Kellman appears in our data through filings on Chem RX Corp shares, published by SEC (Form 4). Over a trading history stretching from 24 January 2008 to 16 January 2009, the count stands at 5 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 21 January 2009 came the latest disclosure, a share grant in Chem RX Corp. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.